限时广告
Technical Guide proton heavy ion therapy→
WhatsApp: +8615316519879 · [email protected]

Hodgkin Lymphoma Medications and Clinical Trials: Accessibility and Evidence in China

Clinical Trials & Advanced Therapies · Updated 19/09/2026 Read about 13 minutes

Hodgkin lymphoma is one of the most treatable cancers, and that fact shapes everything about how trials and new agents should be considered. For most patients, standard chemotherapy with or without radiotherapy is curative. Newer agents matter mainly at relapse, in refractory disease, and in patients who cannot tolerate standard regimens.

The standard picture

Early-stage disease is usually treated with combined modality therapy or abbreviated chemotherapy, guided by interim PET response. Advanced disease is treated with multi-agent chemotherapy, with escalated regimens for patients whose interim scan shows inadequate response. Brentuximab vedotin and checkpoint inhibitors have moved into earlier lines in some protocols and are well established in relapse.

Where trials genuinely add value

  • Relapsed or refractory disease after autologous transplant
  • Patients with comorbidity that rules out standard chemotherapy
  • Consolidation strategies after transplant, including maintenance approaches
  • Antibody-drug conjugates and bispecific agents in earlier lines, in controlled studies

Questions before considering a trial instead of standard care

  • Is the standard regimen still expected to be curative in this case? If so, why replace it?
  • What is the response assessment schedule, and what happens if response is inadequate?
  • Does the protocol allow a later transplant if needed?
  • Is the trial randomised, and what is the comparator?

Documents that decide eligibility

Excisional biopsy pathology with review slides, PET-CT at baseline, and a full treatment history including response to each line. For relapsed disease, the date and type of prior transplant matter as much as the drugs used.

Next step: send the pathology report, PET-CT report and treatment history, and we will map which standard and trial options are realistic for this stage.

Explore Our Medical Guides